Delivery Order SPE2DB25D3006-SPE2DB25FXKKM
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,885.33 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a pharmaceutical delivery under the company's existing contract vehicle with DLA. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) at a ceiling value of $1,846.22. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $14,427.52 delivery order to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed-price contract structure. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This contract represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,683.99 for 60 tablets of Xifaxan 550 mg on September 8, 2025, with completion scheduled for September 9, 2025. This competitive award utilizes a firm fixed-price contract type with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a competitive delivery order valued at $4,651.90 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, using firm fixed pricing with no set-aside designation. The award represents a child delivery order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed-price contract with a ceiling value of $13,089.77 and an ultimate completion date of September 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a $1,999.47 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 30, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $77,218.07. This is a firm fixed price, non-competitive delivery order to be completed by July 31, 2025. The contract is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $2,286.26 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement valued through...
- This delivery order, valued at $7,468.15, was awarded to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) to support federal medical procurement needs. The contract represents a non-set-aside, competitively awarded delivery order with firm fixed pricing, reflecting open competition among qualified vendors. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, with an ultimate completion...